The Global Cardiac Biomarker Diagnostic Test Kits Industry is poised for an unprecedented surge, propelled by a projected worth of US$ 1,950 million in 2023 and an impressive compound annual growth rate (CAGR) of 5.1% forecasted from 2023 to 2033. According to industry experts, this trajectory indicates a substantial valuation of US$ 3,206.73 million by …